While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...

Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.

In the most recent trading session, Novavax (NVAX) closed at $12.80, indicating a -0.85% shift from the previous trading day.

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

For those who are uninsured or under-insured, CDPH will have vaccine at its three CDPH Immunization Clinics. Walk-ins are ...

The Novavax vaccine, which was approved by the FDA at the end of August, is the only non-mRNA updated COVID vaccine that is ...

With the approval of Moderna's updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans ...

There's a new bulletin from Florida's surgeon general. Vaccine experts and historians interviewed for this article can’t ...

Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the ...

COVID-19 numbers are on the rise in the N.W.T., with 54 known cases counted between June and August this year. That's four ...

The US government plans to make more at-home Covid-19 tests available for free this month as the country heads into ...